Patent ID: 11952593
Assignee: nan
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  G | IPC C  G

Claim 14:
15. The method of claim 1, wherein the in vitro method further comprises:
culturing cancer cells in the presence or absence of a known compound for treating cancer for a predetermined period of time;
identifying cell subgroups P1 through P8 in DNV; and
counting numbers of P1 and/or P1 and P2 cell subgroups and P3 through P8 cell subgroups produced during the predetermined period of time in the presence or absence of the known compound, wherein a larger proportion of the Ph and/or P1 and P2 cell subgroups of the total number of P1 through P8 cell subgroups in the cancer cells cultured in the presence of the known compound as compared to the proportion of the P1 and/or P1 and P2 cell subgroups of the total number of P1 through P8 cell subgroups in the cancer cells cultured in the absence of the known compound predicts the compound's ability to inhibit the multinucleate cell production resulting from post-mitotic cell fusion during DNV; and
wherein the compound is determined to treat cancer if the compound's ability to inhibit the multinucleate cell production resulting from post-mitotic cell fusion during DNV is greater than or equal to the known compound's ability to inhibit the multinucleate cell production resulting from post-mitotic cell fusion during DNV.